Adgero Biopharmaceuticals Holdings' Corporate Minority Round

Adgero Biopharmaceuticals Holdings raised a round of funding on February 22, 2017. Investors include Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co..

Adgero Biopharmaceuticals Holdings is a privately-held biopharmaceutical company focused on building a robust pipeline by advancing its proprietary late stage photodynamic therapy (PDT) product with b…

Articles about Adgero Biopharmaceuticals Holdings' Corporate Minority Round: